Open AccessTHE EFFECTIVENESS OF THE TREATMENT OF TUBERCULOSIS, COMBINED WITH HIV INFECTION IN THE TB FACILITY OF THE FEDERAL PENITENTIARY SERVICE, DEPENDING ON THE TYPE OF DRUG RESISTANCE OF THE PATHOGEN
Author(s) -
V. S. Borovitsky
Publication year - 2019
Publication title -
vič-infekciâ i immunosupressii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 4
eISSN - 2078-1792
pISSN - 2077-9828
DOI - 10.22328/2077-9828-2019-11-3-64-70
Subject(s) - tuberculosis , human immunodeficiency virus (hiv) , drug resistance , mycobacterium tuberculosis , medicine , drug resistant tuberculosis , drug , multiple drug resistance , pathogen , directly observed therapy , virology , immunology , microbiology and biotechnology , pharmacology , biology , pathology
The aim : the effectiveness of the treatment tuberculosis combined with HIV infection in TB facilities of the Federal Penitentiary Service (FSIN), depending on the type of drug resistance. Materials and methods . 239 prisoners sick TB with HIV co-infection. Age: from 19 to 56 years. Results . At 50% Patients with tuberculosis, co-infected with HIV infection at Anti-tuberculosis Institution Federal Penitentiary Service will be discontinued as a result of bacterial excretion microscopy within 2 months with drug-sensitive Mycobacterium tuberculosis (Mb) 3 months from the mono-and poly-resistant and 4 months multidrug resistant (MDR). By results of seeding for 3 months drug-sensitive Mb, mono-and poly-resistant; and 4 months MDR. Will be closed cavity disintegration within 3 months from the mono-resistant, 4 months for drug-sensitive Mb, 5 months with poly- and MDR Mb.